You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
16 July 2026 - Biotechnology company Valerio Therapeutics (Euronext Growth Paris:ALVIO) on Thursday announced a binding term sheet with Abivax for an exclusive global research and development collaboration, with final terms subject to a definitive co...
16 July 2026 - Clinical-stage biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT) on Wednesday announced preclinical safety data for its Nu-3 gel formulation that establishes a strong foundation for clinical dose selection in an u...
16 July 2026 - Medical equipment company Vector Science & Therapeutics Corp (TSXV:PAIN) announced on Wednesday the expansion of its intellectual property portfolio to 15 patent applications developed and filed over approximately the past two year...
16 July 2026 - Intensity Therapeutics Inc (Nasdaq:INTS), a late-stage clinical biotechnology company, announced on Wednesday that new patients have been administered INT230-6 in the INVINCIBLE-4 Study in Switzerland.The study analyses INT230-6 given ...
15 July 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Wednesday that its Phase 3 KEYNOTE-C93 trial evaluating KEYTRUDA (pembrolizumab) met its primary endpoint of progression-free...
15 July 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Wednesday that the US Food and Drug Administration (FDA) has granted priority review to its supplemental Biologics License Applica...
15 July 2026 - Lynk Pharmaceuticals Co Ltd, a clinical-stage drug development company focused on immune and inflammatory diseases, announced on Tuesday the completion of patient enrolment in the Phase III clinical trial evaluating its core product ze...